Biomedical Engineering Reference
In-Depth Information
Bruellhoff K, Fiedler J, Oller MM, Groll J, Brenner RE (2010) Surface coating strategies to
prevent biofilm formation on implant surfaces. Int J Artif Organs 33:646-653
Brussow H (2012) Pseudomonas biofilms, cystic fibrosis, and phage: a silver lining? mBio 3:
e00061-12. doi: 10.1128/mBio.00061-12
Cameotra SS, Makkar RS (2004) Recent applications of biosurfactants as biological and immu-
nological molecules. Curr Opin Microbiol 7:262-266
Carlson RP, Taffs R, Davison WM, Stewart PS (2008) Anti-biofilm properties of chitosan-coated
surfaces. J Biomat Sci 19:1035-1046
Carratala J (2002) The antibiotic-lock technique for therapy of “highly needed” infected catheters.
Clin Microbiol Infect 8:282-289
Chaignon P, Sadovskaya I, Ragunah C, Ramasubbu N, Kaplan JB, Jabbouri S (2007) Suscepti-
bility of staphylococcal biofilms to enzymatic treatments depends on their chemical composi-
tion. Appl Microbiol Biotechnol 75:125-132
Chole R, Faddis B (2003) Anatomical evidence of microbial biofilms in tonsillar tissues, a possible
mechanism to explain chronicity. Arch Otolaryngol Head Neck Surg 129:634-636
Christner M, Franke GC, Schommer NN et al (2010) The giant extracellular matrix-binding
protein of Staphylococcus epidermidis mediates biofilm accumulation and attachment to
fibronectin. Mol Microbiol 75:187-207
Chuang YP, Fang CT, Lai SY, Chang SC, Wang JT (2006) Genetic determinants of capsular
serotype K1 of Klebsiella pneumoniae causing primary pyogenic liver abscess. J Infect Dis
193:645-654
Coates T, Eady A, Cove J (2003) Propionibacterial biofilms cannot explain antibiotic resistance
but might contribute to some cases of antibiotic recalcitrant acne. Br J Dermatol 148:366-367
Collins TL, Markus EA, Hassett DJ, Robinson JB (2010) The effect of a cationic porphyrin on
Pseudomonas aeruginosa biofilms. Curr Microbiol 61:411-416
Colvin VL (2003) The potential environmental
impact of engineered nanomaterials. Nat
Biotechnol 21:1166-1170
Contreras-Garcia A, Bucio E, Brackmanc G, Coenye T, Concheiro A, Alvarez-Lorenzo C (2011)
Biofilm inhibition and drug-eluting properties of novel DMAEMA-modified polyethylene and
silicone rubber surfaces. Biofouling 27:123-135
Cornelissen A, Ceyssens PJ, T'Syen J, Van Praet H, Noben JP, Shaburova OV, Krylov VN,
Volckaert G, Lavigne R (2011) The T7-related Pseudomonas putida phage Q15 displays
virion-associated biofilm degradation properties. PLoS ONE 6:e18597. doi: 10.1371/journal.
pone.001 8597
Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent
infections. Science 284:1318-1322
Craigen B, Dashiff A, Kadouri DE (2011) The use of commercially available alpha-amylase
compounds to inhibit and remove Staphylococcus aureus biofilms. Open Microbiol J 5:21-31
Dalleau S, Cateau E, Berges T, Berjeaud JM, Imbert C (2008) In vitro activity of terpenes against
Candida biofilms. Int J Antimicrob Agents 31:572-576
Damte D, Gebru E, Lee SJ, Suh JW, Park SC (2013) Evaluation of anti-quorum sensing activity of
97 indigenous plant extracts from Korea through bioreporter bacterial strains
Chromobacterium violaceum and Pseudomonas aeruginosa . J Microb Biochem Technol
5:42-46
Davey ME, Caiazza NC, O'Toole GA (2003) Rhamnolipid surfactant production affects biofilm
architecture in Pseudomonas aeruginosa PAO1. J Bacteriol 185:1027-1036
Davies D (2003) Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov
2:114-122
Davies DG, Marques CN (2009) A fatty acid is responsible for inducing dispersion in microbial
biofilms. J Bacteriol 191:1393-1403
Davies AN, Brailsford SR, Beighton D (2006) Oral candidosis in patients with advanced cancer.
Oral Oncol 42:698-702
Search WWH ::




Custom Search